Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,389 public trials 159 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Completed

Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit

NCT01527838

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Chronic Disease, +26 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program Boston, Massachusetts, United States
  • Ohio State Univeristy Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Completed

Fludarabine and Monoclonal Antibody Therapy in Treating Patients With Untreated B-cell Chronic Lymphocytic Leukemia

NCT00003248

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • University of California San Diego Cancer Center La Jolla, California, United States
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • CCOP - Christiana Care Health Services Wilmington, Delaware, United States
  • Walter Reed Army Medical Center Washington D.C., District of Columbia, United States
View all 34 locations
View Trial Details
Completed

Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma

NCT00006252

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
Locations
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • Veterans Affairs Medical Center - San Diego San Diego, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
  • Beebe Medical Center Lewes, Delaware, United States
View all 19 locations
View Trial Details
Completed

Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies

NCT01871675

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +22 more
Locations
  • The Colorado Blood Cancer Institute Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Oklahoma University Oklahoma City, Oklahoma, United States
  • Tennessee Oncology, PLLC Nashville, Tennessee, United States
View Trial Details
Completed

Ribomustin in the First Line Therapy of Chronic Lymphocytic Leukemia

NCT02110394

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Republic Clinical Hospital n.a. N.A. Semashko Buryatia, Ulan-Ude, Russia
  • Alexandro-Mariinskaia Regional Clinical Hospital/13 Astrakhan, Russia
  • Vologda Reginal Clinical Hospital #2 Cherepovets, Russia
  • Irkutsk Regional Clinical Hospital/08 Irkutsk, Russia
View all 34 locations
View Trial Details

Related conditions